Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex

Virology Journal

Volumn 6, Issue , 2009, Pages

  Erez, Noam ^a   Paran, Nir ^a   Maik Rachline, Galia ^a   Politi, Boaz ^a   Israely, Tomer ^a   Schnider, Paula ^a   Fuchs, Pinhas ^a,b   Melamed, Sharon ^a   Lustig, Shlomo ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL FUSION; CELL MEMBRANE; CONTROLLED STUDY; ECTROMELIA VIRUS; GIANT CELL; HUMAN; HUMAN CELL; MOUSEPOX; NONHUMAN; RESPIRATORY TRACT INFECTION; VACCINIA VIRUS; VIRUS PARTICLE; VIRUS REPLICATION; ANIMAL; CELL LINE; LUNG; MOUSE; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ECTROMELIA VIRUS; MUS; VACCINIA VIRUS;

VIRUS PROTEIN;

ANIMALS; CELL FUSION; CELL LINE; ECTROMELIA VIRUS; HUMANS; LUNG; MICE; VIRAL PROTEINS;

EID: 70350007951     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-151     Document Type: Article

References (32)

1. Poxvirus entry and membrane fusion. B Moss, Virology 2006 344 48 54 10.1016/j.virol.2005.09.037 16364735
2. The formation and function of extracellular enveloped vaccinia virus. GL Smith A Vanderplasschen M Law, J Gen Virol 2002 83 2915 2931 12466468
3. Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. GC Carter M Law M Hollinshead GL Smith, J Gen Virol 2005 86 1279 1290 10.1099/vir.0.80831-0 15831938
4. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. TR Wagenaar B Moss, J Virol 2007 81 6286 6293 10.1128/JVI.00274-07 17409143
5. Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Y Ichihashi S Dales, Virology 1971 46 533 543 10.1016/0042-6822(71)90057-2 4109523
6. Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion. PC Turner RW Moyer, J Virol 1995 69 5978 5987 7666502
7. The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells. PC Turner RW Moyer, Virology 2006 347 88 99 10.1016/j.virol.2005.11.012 16378629
8. The pathogenesis of the acute exanthems; an interpretation based on experimental investigations with mousepox; infectious ectromelia of mice. F Fenner, Lancet 1948 2 915 920 10.1016/S0140-6736(48)91599-2 18101995
9. The exit of vaccinia virus from infected cells. GL Smith M Law, Virus Res 2004 106 189 197 10.1016/j.virusres.2004.08.015 15567497
10. Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus. TP Newsome I Weisswange F Frischknecht M Way, Cell Microbiol 2006 8 233 241 10.1111/j.1462-5822.2005.00613.x 16441434
11. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. PM Reeves B Bommarius S Lebeis S McNulty J Christensen A Swimm A Chahroudi R Chavan MB Feinberg D Veach, et al. Nat Med 2005 11 731 739 10.1038/nm1265 15980865
12. Biogenesis of vaccinia: molecular basis for the hemagglutination-negative phenotype of the IHD-W strain. H Shida S Dales, Virology 1982 117 219 237 10.1016/0042-6822(82)90521-9 6175083
13. Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex. TR Wagenaar S Ojeda B Moss, J Virol 2008 82 5153 5160 10.1128/JVI.00162-08 18353946
14. Differentiation of ectromelia virus haemagglutinin from haemagglutinins of other poxviruses. T Mills BC Pratt, Arch Virol 1980 63 153 157 10.1007/BF01320773 7356392
15. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. PC Turner RW Moyer, J Virol 1992 66 2076 2085 1548753
16. In vivo and in vitro characterization of two camelpoxvirus isolates with decreased virulence. CK Otterbein H Meyer IC Renner-Muller E Munz, Rev Elev Med Vet Pays Trop 1996 49 114 120 9008960
17. The detection of monkeypox in humans in the Western Hemisphere. KD Reed JW Melski MB Graham RL Regnery MJ Sotir MV Wegner JJ Kazmierczak EJ Stratman Y Li JA Fairley, et al. N Engl J Med 2004 350 342 350 10.1056/NEJMoa032299 14736926
18. Further characterization of Raccoonpox virus. EK Thomas EL Palmer JF Obijeski JH Nakano, Arch Virol 1975 49 217 227 10.1007/BF01317540 813616
19. The many mechanisms of viral membrane fusion proteins. LJ Earp SE Delos HE Park JM White, Curr Top Microbiol Immunol 2005 285 25 66 full-text 15609500
20. Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. AC Townsley AS Weisberg TR Wagenaar B Moss, J Virol 2006 80 8899 8908 10.1128/JVI.01053-06 16940502
21. Brefeldin A inhibits vaccinia virus envelopment but does not prevent normal processing and localization of the putative envelopment receptor P37. D Ulaeto D Grosenbach DE Hruby, J Gen Virol 1995 76 Pt 1 103 111 10.1099/0022-1317-76-1-103 7844519
22. Vaccinia virus utilizes microtubules for movement to the cell surface. M Hollinshead G Rodger H Van Eijl M Law R Hollinshead DJ Vaux GL Smith, J Cell Biol 2001 154 389 402 10.1083/jcb.200104124 11470826
23. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. BM Ward B Moss, J Virol 2001 75 11651 11663 10.1128/JVI.75.23.11651-11663.2001 11689647
24. The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus. PC Turner RW Moyer, Virology 2008 380 226 233 10.1016/j.virol.2008.07.020 18760436
25. Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. TR Wagenaar B Moss, J Virol 2009 83 1546 1554 10.1128/JVI.01684-08 19036815
26. Biogenesis of vaccinia: isolation and characterization of a surface component that elicits antibody suppressing infectivity and cell-cell fusion. W Stern S Dales, Virology 1976 75 232 241 10.1016/0042-6822(76)90022-2 982851
27. Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. M Seki M Oie Y Ichihashi H Shida, Virology 1990 175 372 384 10.1016/0042-6822(90)90422-N 2183466
28. Further analyses of the orthopoxviruses volepox virus and raccoon poxvirus. JC Knight CS Goldsmith A Tamin RL Regnery DC Regnery JJ Esposito, Virology 1992 190 423 433 10.1016/0042-6822(92)91228-M 1529541
29. Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice. S Melamed N Paran L Katz D Ben-Nathan T Israely P Schneider R Levin S Lustig, Vaccine 2007 25 7743 7753 10.1016/j.vaccine.2007.09.023 17928110
30. JC Hierhozler RA Killington, Virus isolation and quantitaion Academic Press 1996
31. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. C Fogg S Lustig JC Whitbeck RJ Eisenberg GH Cohen B Moss, J Virol 2004 78 10230 10237 10.1128/JVI.78.19.10230-10237.2004 15367588
32. Induction of apoptosis in cultured endothelial cells by a cadherin antagonist peptide: involvement of fibroblast growth factor receptor-mediated signalling. N Erez E Zamir BJ Gour OW Blaschuk B Geiger, Exp Cell Res 2004 294 366 378 10.1016/j.yexcr.2003.11.033 15023527